Health
Pancreatic Cancer Drug Approved, Access Issues Persist
The FDA approved a new pancreatic cancer drug called Rasonque. However, patients face challenges accessing the treatment due to logistical issues.
Coverage timeline — 1 article
STAT News
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
2026-09-08 08:30 UTC